Determination of nutlin-3a in murine plasma by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS)

被引:6
作者
Bai, Feng [1 ]
Zhu, Fangyi [2 ]
Tagen, Michael [1 ]
Miller, Laura [1 ]
Owens, Thandranese S. [1 ]
Mallari, Jeremy [1 ]
Derrick, Edward [1 ]
Zhang, Fan [1 ]
Stewart, Clinton F. [1 ,2 ,3 ]
机构
[1] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA
[3] Univ Tennessee, Dept Pediat, Coll Med, Memphis, TN 38105 USA
关键词
Nutlin-3a; Liquid-liquid extraction (LLE); Protein precipitation (PP); Liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS); MDM2; ONCOPROTEIN; HUMAN TUMORS; P53; PATHWAY; CELL-DEATH; IN-VIVO; CANCER; TRANSACTIVATION; RETINOBLASTOMA; KETOCONAZOLE; ANTAGONISTS;
D O I
10.1016/j.jpba.2009.10.016
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A sensitive and precise LC-ESI-MS/MS method for determination of nutlin-3a in murine plasma using ketoconazole as an internal standard was developed and validated. Plasma nutlin-3a samples were prepared by either a simple protein precipitation (PP) for the high concentration range (10-20,000 ng/mL) or by liquid-liquid extraction (LLE) for the low concentration range (0.25-300 ng/mL). Nutlin-3a and ketoconazole were separated on a modified C18 analytical column (4 mu m, 75 mm x 2 mm) with an isocratic mobile phase (acetonitrile/5 mM HCOONH4 = 70/30, v/v). The retention times of nutlin-3a and ketoconazole were 1.14 and 1.45 min. Detection was achieved by a tandem MS system, monitoring m/z 582/99 and m/z 532/82 for nutlin-3a and ketoconazole, respectively. The PP method was linear in a range of 10-20,000 ng/mL (R-2 >= 0.993) and the LLE method was linear in a range of 0.25-300 ng/mL (R-2 >= 0.992). The mean recoveries for PP and LLE were 24% and 78%, respectively. Within-day and between-day precisions were <= 4.5% for PP and were <= 4.9% for LLE. Within-day and between-day accuracies (% error) ranged from 4.8 to -7.9 for PP, and from -0.2 to -8.4 for LLE. The two extraction methods produced equivalent results, allowing use of both within the same study. This method has been applied to the measurement of nutlin-3a concentrations in murine plasma samples obtained from a preclinical pharmacokinetic study. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 18 条
[1]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[2]   MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death [J].
Barbieri, Eveline ;
Mehta, Parth ;
Chen, Zaowen ;
Zhang, Linna ;
Slack, Andrew ;
Berg, Stacey ;
Shohet, Jason M. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (09) :2358-2365
[3]   MDM2 is a central node in the p53 pathway: 12 years and counting [J].
Bond, GL ;
Hu, WW ;
Levine, AJ .
CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :3-8
[4]   Determination of ketoconazole in human plasma by high-performance liquid chromatography - tandem mass spectrometry [J].
Chen, YL ;
Felder, L ;
Jiang, XY ;
Naidong, W .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 774 (01) :67-78
[5]   Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells [J].
Elison, Jasmine R. ;
Cobrinik, David ;
Claros, Nidia ;
Abramson, David H. ;
Lee, Thomas C. .
ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (09) :1269-1275
[6]   Functions of the MDM2 oncoprotein [J].
Freedman, DA ;
Wu, L ;
Levine, AJ .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :96-107
[7]   Identification of an aberrantly spliced form of HDMX in human tumors: A new mechanism for HDM2 stabilization [J].
Giglio, S ;
Mancini, F ;
Gentiletti, F ;
Sparaco, G ;
Felicioni, L ;
Barassi, F ;
Martella, C ;
Prodosmo, A ;
Iacovelli, S ;
Buttitta, F ;
Farsetti, A ;
Soddu, S ;
Marchetti, A ;
Sacchi, A ;
Pontecorvi, A ;
Moretti, F .
CANCER RESEARCH, 2005, 65 (21) :9687-9694
[8]   MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2 [J].
Gu, L. ;
Zhu, N. ;
Findley, H. W. ;
Zhou, M. .
LEUKEMIA, 2008, 22 (04) :730-739
[9]  
HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551
[10]   Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain [J].
Kussie, PH ;
Gorina, S ;
Marechal, V ;
Elenbaas, B ;
Moreau, J ;
Levine, AJ ;
Pavletich, NP .
SCIENCE, 1996, 274 (5289) :948-953